Erin McEvoy

The internship will provide hands-on experience in medical cannabis cultivation in the country’s expanding medical cannabis market.

In response to the recent announcement that the hearing concerning cannabis rescheduling had been delayed, Americans for Safe Access held a webinar discussing the impacts medical cannabis.

The facility will prioritize consumer safety, regulatory compliance, and high-quality cannabis products.

The Marijuana Policy Project examined national and state-level data on percentages of student cannabis use before and after cannabis laws were enacted.

Cannabis legalization and regulation was noted as an issue with longtime support of a majority of voters in the state.

Kentucky launched its medical cannabis program on January 1, 2025, allowing patients with qualifying conditions to apply for ID cards.

Sales of recreational cannabis began a few months ago in the state.

It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2024. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!

The study analyzed data from three adult age groups on daily or near daily cannabis and alcohol use.

In late January 2025 the survey will be sent to hemp producers in six states.

As we begin the year 2025, let’s review the most popular trends and topics in webinars covered by Cannabis Science and Technology in 2024.

Listen to a Noid Factoid from Yasha Kahn, co-founder of MCR Labs.

Check out the complete series from our Cannabis Analysis column.

A nationally representative survey revealed adolescent cannabis use trends for 2024.

The single-state companies involved in the merger are anticipated to continue their operations independently with the support of Vireo.

The patient-centered organization announced its 2025 plans for medical cannabis at the national level.

As bat guano becomes more commonly used in cannabis cultivation, a recent study highlights the negative effects that can come with using this type of fertilizer.

With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.

With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.

The December webinar from Healer featured several studies on various conditions treated with medical cannabis.

Founder of S. A. Audino & Associates, LLC, Susan Audino, PhD, recently co-founded Saturn Scientific, LLC, a collaboration of five experienced individuals providing unbiased evaluations on the data and science for stakeholders in the cannabis industry. In this interview with Cannabis Science and Technology, Dr. Audino shares her unexpected path into analytical science and the cannabis industry as well as the obstacles she’s faced throughout her career. She highlights the gender bias she’s observed, such as unequal recognition of credentials and workplace challenges, while advocating for inclusivity and mentorship to empower women in science. Additionally, Dr. Audino recounts her experiences of navigating the male-dominated cannabis space, pushing for transparency, collaboration, and integrity in laboratory practices. Ultimately, Audino believes fostering mutual respect and knowledge-sharing is vital for the industry’s growth and resilience.

In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.

A study involving older adults revealed correlation between CBD use and health issues.

The study aimed to evaluate short-term, repeated use of low dose CBD and intense exercise.

Researchers examined a half-dozen medical records involving CBD used to treat THC toxicosis in dogs.

A recent review explored the connection between ADHD symptoms, cannabis use, the ECS, and potential therapeutic effects.

Accredited by A2LA, the scope of accreditation to ISO/IEC 17043 now includes six cannabis and hemp oil proficiency testing programs.

The recently passed amendment deprioritized cannabis enforcement in Dallas, Texas.

This month’s GMP Collective webinar focused on how collaboration within the industry can lead to overall growth and success.

A recent study explored cannabis use and age-related cognitive decline in men, taking into account first use of cannabis and usage frequency.